The diagnostic criteria for MS reflect a growing understanding of the condition and the application of new advancements in medical technology to help improve diagnostic accuracy and reliability.

Misdiagnoses of multiple sclerosis (MS) represent one of the prominent challenges in MS for patients, clinicians, and researchers. A variety of factors influence misdiagnosis, including testing ...

Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect ...

No single test can confirm multiple sclerosis (MS) or discount it. Instead, doctors test for MS by ruling out other possible diagnoses and then looking for signs of MS-related damage. MS is an ...

Imaging is a crucial tool in the diagnosis of MS. Magnetic resonance imaging (MRI) reveals multiple demyelinated lesions scattered throughout the CNS, marked by inflammation, edema, glial reaction and ...

There is no single test that unequivocally detects MS. When faced with a patient whose symptoms, neurological exam results, and medical history suggest MS, physicians use a variety of tools to look ...

Epstein-Barr virus-positive infectious mononucleosis (EBV-mono) is associated with a threefold higher multiple sclerosis risk ...

SAN DIEGO — Researchers identified patients who tested positive for the Epstein-Barr Virus (EBV) 9 years after they were diagnosed with multiple sclerosis (MS), challenging the idea that MS always ...

Persistent EBNA-1 peptide IgG antibody levels may help distinguish multiple sclerosis from other neuroinflammatory diseases like MOGAD and NMOSD.

Siemens Healthineers received European approval for a blood test designed to help predict the risk of recurrence among patients with relapsing multiple sclerosis. The company’s CE-marked in vitro ...